// App-Quantinova.ai

4042 : An update on the randomized phase III POST trial: S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer.

Researchers

Presenter

  • Choong-kun Lee

Principal Investigators

  • Minkyu Jung

  • Hyo Song Kim

  • Inkyung Jung

  • Dong Bok Shin

  • Seok Yun Kang

  • Dae Young Zang

  • Ki Hyang Kim

  • Moon Hee Lee

  • Bong-Seog Kim

  • Kyung Hee Lee

  • Ji Yeong An

  • Hyoung-Il Kim

  • Jae-Ho Cheong

  • Woo Jin Hyung

  • Sung Hoon Noh

  • Hyun Cheol Chung

  • Sun Young Rha

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Cisplatin

Outcome

  • N/A


Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT01283217

Sponsors

  • N/A

Result

  • Final